FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1962561 · Received January 18, 2011

Report

Report Number
2134265-2010-05983
Event Type
Injury
Date Received
January 18, 2011
Date of Event
November 18, 2010
Report Date
December 20, 2010
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).DEVICE IS COMBINATION PRODUCT.DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.(B)(4)

Description of Event or Problem · 1

(B)(6) CLINICAL STUDY. IT WAS REPORTED THAT DURING A CORONARY DRUG ELUTING STENTING TREATMENT PROCEDURE, THE STUDY STENT DID NOT FULLY EXPAND. THE INDEX PROCEDURE TREATED THE 80% STENOSED, 2.75X13MM TARGET LESION LOCATED IN THE DISTAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. TREATMENT CONSISTED OF PRE DILATION AND THE PLACEMENT OF A 2.75X28MM (B)(6) STUDY STENT. POST IVUS WAS PERFORMED REVEALING THE STENT WAS UNDER EXPANDED. TREATMENT CONSISTED OF ADDITIONAL POST DILATIONS WITH A NON-COMPLIANT BALLOON RESULTING IN 0% RESIDUAL STENOSIS. THE PATIENT WAS DISCHARGED THE NEXT DAY ON ASPIRIN AND PRASUGREL.

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT A PERIPROCEDURAL MI OCCURRED ONE DAY POST THE INDEX PROCEDURE. NO ACTION WAS TAKEN AND THE EVENT RESOLVED WITHOUT RESIDUAL EFFECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493893628270 13671403

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention